Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib/II Dose-finding Study of DDFPe in Patients With Acute Ischemic Stroke

NCT02963376 is registered in ClinicalTrials.gov with NuvOx LLC as lead sponsor.

NCT NCT02963376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02963376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib/II Dose-finding Study of DDFPe in Patients With Acute Ischemic Stroke
Lead sponsor
NuvOx LLC
Phase
Phase 1
Overall status
Completed
Start date
February 1, 2017
Completion date
July 9, 2018
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke